Acquisition Opportunity Recent acquisition by VION Biosciences signals new ownership that could unlock a strategic distribution and co selling channel for Echelon's lipid and lipid nanoparticle reagents. Engage VION leadership to explore integrating Echelon's specialty lipids, assays, and kits into VION's portfolio and global sales network.

Proven Regional Partners Echelon has successfully extended its reach through distribution partnerships in Singapore and the Asia Pacific region. This model can be replicated to accelerate market penetration in additional regions, supported by existing partner incentives and joint marketing.

ELISA Leadership Award recognition in ELISA underscores strength in reagent kits and assay components. Target laboratories seeking reliable ELISA solutions, and position Echelon as a preferred supplier for high quality kits and associated proteins.

Lipid Platform Synergy Product launches in Lipid Microparticles and Lipid Protein Interaction Tools align with the growing lipid nanoparticle sector. Propose cross selling of lipid reagents to pharmaceutical developers working on lipid based delivery and formulation research.

Customer Focused Growth As a small to mid sized biotech supplier with a global footprint and a strong customer service focus, Echelon can win business from mid market pharma, biotech and academic accounts needing agile, high quality reagents. Consider pilots and flexible pricing to drive trials.